跳至主要内容
临床试验/NL-OMON38884
NL-OMON38884已完成不适用

Increased thrombogenicity in patients with atherosclerosis of the peripheral arteries of the lower extremities: a case-control study. - Changes in the coagulation in patients with peripheral arterial disease

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients who have entered the PAD study, as PAD the novo with an EAI<0,9, and did (cases) or did not (controls) reach an endpoint within 1 year of follow-up.

排除标准

  • - Patients with known coagulopathies (coagulation disorders)
  • - Pregnancy
  • - Chronic Inflammatory Disorders
  • - Anti-phospholipid syndrome
  • - Malignancies
  • - Systemic anticoagulation (acenocoumarol, fenprocoumon, dabigatran, rivaroxaban)

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验